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Objectives: The aim of this study was to validate the Brief Assessment of Impaired
Cognition (BASIC) and the Brief Assessment of Impaired Cognition Questionnaire
(BASIC-Q) for identification of mild cognitive impairment (MCI) in a memory clinic
setting.
Methods: A total of 163 sociodemographically matched patients (MCI, n = 42, and
dementia, n = 121) and 83 control participants were included in the study. Two
instruments were validated: (a) BASIC, including the components self-report, infor-
mant report, and two brief cognitive tests, and (b) BASIC-Q, including the compo-
nents self-report, informant report, and orientation. BASIC can be administered in
5 minutes and BASIC-Q in less than 5 minutes.
Results: A high discriminative validity for MCI vs control participants was found for
both BASIC (sensitivity 0.86, specificity 0.89) and BASIC-Q (sensitivity 0.88, specific-
ity 0.88). In comparison, the MMSE had low sensitivity (0.61) and moderate specific-
ity (0.72). All components of BASIC and BASIC-Q contributed significantly to
differentiate MCI from control participants. The components of BASIC and BASIC-Q
also contributed significantly to differentiate MCI from dementia, except for self-
report, which was identical in the two groups.
Conclusions: Both BASIC and BASIC-Q are brief, valid, and effective instruments for
identification of patients with possible MCI in a memory clinic setting. Further cross-
validation of the instruments in a general practice or primary care setting is needed.
K E YWORD S
BASIC, BASIC-Q, cognitive assessment, cognitive screening, dementia, diagnostic accuracy,
discriminative validity, mild cognitive impairment, predictive validity
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1 | INTRODUCTION
Brief, accurate, and practical case-finding instruments are highly rele-
vant for identification of mild cognitive impairment (MCI) in a clinical
setting. MCI is clinically defined as a condition where the person is
not cognitively intact, but without dementia, and with preserved basic
activities of daily living. Historically, clinical criteria for MCI, focusing
on memory impairment, were initially defined by Ronald Petersen,1,2
but in 2004 a broader conception including both amnestic and non-
amnestic MCI-subtypes was introduced3,4 which has essentially been
adopted by subsequent definitions and elaborations of MCI-criteria.5-7
Estimates of the prevalence of MCI from epidemiological studies
show considerable variation which may be attributed to differences in
methodology and definitions of MCI,8 but the majority of studies
report a prevalence in the range of 12% to 18% in people aged
60 years or older.9 In clinical samples, the prevalence is even higher.
Thus, in Danish memory clinics approximately 25% of newly referred
patients are subsequently assigned a diagnosis of MCI.10
In a clinical context, both the differentiation between normal
ageing and MCI and the differentiation between MCI and mild
dementia may be a challenge. Cognitive tests and brief test batte-
ries11-15 are often used for identification of dementia and MCI but
the time needed for test administration (10 minutes or more) may be
a disadvantage in a busy clinical setting, test performance may be
influenced by sociodemographic variables such as education and
age,16-23 and some test items (such as Serial sevens in The Mini-
Mental State Examination, MMSE,11 and in the Montreal Cognitive
Assessment, MoCA12) may be perceived as difficult or confronta-
tional possibly causing unnecessary discouragement during testing.
According to a meta-analysis of 19 studies,24 the MMSE has accept-
able specificity but low sensitivity for detection of MCI vs healthy
controls. A systematic review of cognitive screening instruments for
identification of MCI vs controls from 2009 identified 15 screening
measures, four of which had sensitivity and specificity values ≥0.79,
whereas the rest performed less favourably.25 Another systematic
review identified more than 40 brief cognitive instruments for iden-
tification of amnestic MCI vs controls, of which the MoCA was the
most comprehensively investigated.26 Neuropsychological measures
of immediate and delayed memory generally have acceptable accu-
racy for detection of MCI vs healthy controls,27 and also seem to be
accurate in predicting progression from MCI to dementia.28 Neuro-
psychological assessment, however, is relatively time consuming and
access to neuropsychological assessment may be limited in clinical
practice. Consequently, there is a need for accurate, time-saving and
nonconfrontational tools for identification of MCI in a clinical
setting.
We have previously developed and validated two new brief case-
finding instruments in a Danish multicenter study: The Brief Assess-
ment of Impaired Cognition (BASIC),29 and the Brief Assessment of
Impaired Cognition Questionnaire (BASIC-Q).30 We found BASIC to
be highly accurate in classifying dementia (sensitivity 0.98, specificity
0.95), while BASIC-Q, that is primarily intended for use in community
settings, was highly accurate in classifying cognitive impairment
(including dementia and MCI; sensitivity 0.92, specificity 0.97). Both
instruments appear to be relatively unaffected by sociodemographic
characteristics.29,30 The aim of this study was to examine the ability
of the BASIC and BASIC-Q to identify MCI in a memory clinic setting.
2 | METHODS
BASIC and BASIC-Q include identical self-report and informant report
components, but BASIC additionally includes two brief cognitive tests:
Supermarket Fluency, and Category Cued Memory Test, whereas
BASIC-Q instead includes four orientation items (Table 1).
BASIC and BASIC-Q were inspired by existing, validated instru-
ments31-33 and includes elements from validated questionnaires.34,35
According to interviews with patients and informants, BASIC and
BASIC-Q are perceived as relevant and nonconfrontational.29 A total
BASIC score is obtained by summing the scores of four components
into a composite score (range 0-25 points), whereas a total BASIC-Q
score is obtained by summing the scores of three components into a
composite score (range 0-20 points). If reliable informant report can-
not be obtained, a pro-rated score estimate may be used in both
instruments. Although BASIC and BASIC-Q are separate instruments
intended for use in different settings, they were derived from the
same preliminary instrument and were validated simultaneously in the
Key points
• Accurate, time-saving, and easy-to-use tools for identifi-
cation of mild cognitive impairment (MCI) in a clinical set-
ting are valuable. The present results indicate that
patients with possible MCI for whom further diagnostic
assessment should be considered may be identified by
means of a brief case-finding instrument integrating self-
report and informant report with either cognitive assess-
ment (BASIC) or questions regarding orientation (BASIC-
Q). The administration time for each instrument is
5 minutes or less.
• BASIC and BASIC-Q are perceived by patients and rela-
tives as relevant and nonconfrontational. Both instru-
ments appear to be less affected by education, age, and
gender than more complex instruments such as the Mini-
Mental State Examination (MMSE) or the Montreal Cog-
nitive Assessment (MoCA).
• The self- and informant report components of BASIC and
BASIC-Q are equally valid measures of cognitive impair-
ment early in the process of decline, but as dementia sets
in, the validity of self-report becomes inferior to infor-
mant report, possibly reflecting loss of insight. In con-
trast, the validity of informant report seems to increase
with the progression of cognitive impairment.
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same setting. In this study, we therefore present results for both
instruments regarding identification of MCI.
2.1 | Participants
The study was carried out in accordance with the Code of Ethics of
the World Medical Association for experiments involving humans and
was approved by the Danish Data Protection Agency (RH-2018-34).
Written informed consent was obtained from all participants. A clini-
cal sample and a control sample was included and assessed in 2018.
Inclusion criteria for all participants were (a) age ≥65 years, (b) being
fluent in Danish, (c) a relevant informant (eg, relative) present at the
examination, (d) referred from general practice for diagnostic evalua-
tion. Five Danish outpatient memory clinics recruited participants and
collected data.
Patients were consecutively included at their initial memory clinic
admission and administered a preliminary instrument containing both
BASIC and BASIC-Q. Patients further underwent an extensive diag-
nostic work-up as described in a previous publication.29 Dementia
was diagnosed according to National Institute of Aging and
Alzheimer's Association (NIA-AA) workgroup criteria36 and clinical
research criteria were used for specific subtypes of dementia disor-
ders.37-39 The diagnosis of MCI adhered to revised Petersen
criteria4,40 including both amnestic and nonamnestic phenotypes. All
MCI patients underwent comprehensive neuropsychological assess-
ment including tests of episodic memory (eg, Rey Auditory Verbal
Learning Test,41 Rey Complex Figure Test42), semantic memory/lan-
guage (eg, Boston Naming Test43), executive functions (eg, verbal flu-
ency measures44), processing speed (eg, Trail Making Test45), and
visuoconstructional skills (eg, Block Design Test46). The control sam-
ple was recruited among participating patients' relatives (mainly
spouses) and volunteers from ongoing research projects at the
involved memory clinics. Exclusion criteria for the control sample have
been previously described.29
2.2 | Procedure
The validation of BASIC and BASIC-Q for identification of MCI is
based on further analysis of data from the primary validation of the
two instruments, which was a prospective study in which patients
were assessed prior to diagnosis.29 In most cases, diagnosis was
established 1 to 3 months later. At each site, the preliminary instru-
ment was administered by trained nurses or physicians. Administra-
tion was standardized across memory clinics. Informants concurrently
completed a brief informant report questionnaire. Control participants
served as their own informants. Age, gender, and postsecondary edu-
cation (type and approximate length of education exceeding compul-
sory education), were registered for all participants.
2.3 | Data analysis
The significance of group differences on continuous variables was
determined using independent samples t-test. The significance of
group differences in gender distribution was determined using the
Pearson χ2 test. Effect sizes were calculated as Hedges' g.47 Effect
sizes of 0.2 to 0.5 were considered small, >0.5 to 0.8 were considered
moderate and >0.8 were considered large. Discriminative validity was
assessed by calculating sensitivity, specificity and likelihood ratios
using a clinical diagnosis of MCI as reference standard. The optimal
balance between sensitivity and specificity for discrimination between
groups was determined by Youden's J.48 Receiver operating
TABLE 1 Brief Assessment of Impaired Cognition (BASIC) case-finding instrument and Brief Assessment of Impaired Cognition Questionnaire
(BASIC-Q)
BASIC Score range BASIC-Q Score range
1. Self-report 1. Self-report
Three questions from the Cognitive Function
Instrument (CFI) regarding self-rated memory
functioning
0 to 6 (Items identical to BASIC) 0 to 6
2. Supermarket fluency 2. Orientation
With an interval scoring algorithm 0 to 5 Orientation in time (year, month, day of
week) and orientation in person (age)
0 to 8
3. Category cued memory test
Free and category cued recall of four pictures 0 to 8
4. Informant report 3. Informant report
Three questions from the Informant Questionnaire
of Cognitive Decline (IQCODE) regarding the
cognitive functioning of the patient
0 to 6 (Items identical to BASIC) 0 to 6
BASIC total score 0 to 25 BASIC-Q total score 0 to 20
Note: Optimal BASIC cutoff score for mild cognitive impairment (MCI) vs control group is 21/22. Optimal BASIC-Q cutoff score for MCI vs control group
is 17/18.
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characteristic (ROC) curves for BASIC, BASIC-Q, and MMSE were
constructed and the areas under the curve (AUC) were compared
using the nonparametric approach by DeLong et al49 for correlated
ROC curves. Predictive validity was calculated according to Bayes'
classical theorem.50 Positive predictive validity (PPV) is essentially the
proportion of individuals screening positive at a given cutoff score
and later being assigned a diagnosis of MCI, whereas negative predic-
tive validity (NPV) is the proportion screening negative and being
without MCI. PPV can also be interpreted as an estimate of the proba-
bility of MCI for individuals scoring positive according to a given cutoff,
whereas NPV may work as an estimate of the probability of being with-
out MCI for individuals scoring negative according to the cutoff. The
diagnostic classification performance of BASIC, BASIC-Q and their
components was further estimated by calculating odds ratios
(OR) using binary logistic regression. The OR represents the change in
odds of being in one of two diagnostic categories when the value of
the independent (predictor) variable increases by one unit.51 An online
clinical research calculator (www.vassarstats.net) was used to calculate
95% confidence intervals (CI) for sensitivity, specificity, PPV, and NPV.
MedCalc statistical software was used for comparison of ROC curves
(www.medcalc.org). All other analyses were performed with IBM SPSS
Statistics (version 25). P < .05 (two-tailed) was considered significant.
3 | RESULTS
From the primary BASIC and BASIC-Q validation study, 428 participants
(293 cases and 135 controls) were eligible for inclusion. In the patient
sample, 14% of the participants were diagnosed with MCI, 57% were
diagnosed with dementia and 29% with other, mainly neurological or
psychiatric conditions. To minimize the possible impact of
sociodemographic variables on the discriminative validity analyses, we
selected three sociodemographically matched subsamples through step-
wise exclusion of participants from the control group and dementia
group until statistically significant differences in age, education and gen-
der between the three groups were suspended: (a) an MCI group
(n = 42); (b) a matched control group (n = 83); and (c) a dementia group
(n = 121; Table 2). The mixed clinical sample with neurological or psychi-
atric conditions was not included in the analyses. Sociodemographic and
cognitive characteristics of the included matched samples are summa-
rized in Table 2.
The dementia group included Alzheimer's disease (AD; n = 61), vas-
cular dementia (n = 19), Lewy body dementia (n = 8), mixed dementia
(n = 8), dementia not otherwise specified (n = 8), frontotemporal demen-
tia (n = 7), Parkinson's disease dementia (n = 4), alcohol-related dementia
(n = 3), and other causes of dementia (n = 3). Significant differences with
large effect sizes were present between MCI and controls on BASIC
(t [123] = 10.34, P < .001, g = 2.50) and BASIC-Q (t [123] = 9.86,
P < .001, g = 2.37). A significant difference with a moderate effect size
was found between MCI and controls on MMSE (t [123] = 3.20, P < .01,
g = 0.73; Table 2). Further information regarding the score distribution
for BASIC in the three samples are depicted in Figure 1. Information
regarding the score distributions for BASIC-Q and MMSE in the three
samples are shown in the Figures S1 and S2.
Significant differences with moderate to large effect sizes were
present between MCI and controls on the components of BASIC and
BASIC-Q: Self-report (t [123] = 7.18, P < .001, g = 1.47), Informant
report (t [123] = 8,92, P < .001, g = 2.36), Category Cued Memory Test
TABLE 2 Demographic and cognitive participant characteristics
Controls MCI Dementia
Number 83 42 121
Age (y) 74.7 (5.56) 74.3 (4.77) 76.0 (4.87)
Postsecondary education (y) 2.3 (1.56) 2.4 (1.64) 2.1 (1.52)
Female/male 36/47 11/31 50/71
BASIC (range 0-25) 23.4 (1.31) 17.9 (3.33)a 13.5 (3.70)c
BASIC-Q (range 0-20) 18.9 (1.11) 14.6 (2.76)a 10.9 (3.57)c
MMSE (range 0-30) 28.7 (1.65) 27.0 (3.15)b 22.6 (4.37)c
Components of BASIC and BASIC-Q:
• Self-report (range 0-6) 5.2 (0.92) 3.7 (1.20)a 3.7 (1.63)
• Informant report (range 0-6) 5.8 (0.43) 3.3 (1.71)a 1.8 (1.51)c
• Category cued memory test (range 0-8) 7.7 (0.53) 7.0 (1.33)b 5.6 (2.16)c
• Supermarket fluency (range 0-5) 4.7 (0.74) 3.8 (1.11)a 2.5 (1.32)c
• Orientation (range 0-8) 7.9 (0.38) 7.5 (0.86)b 5.4 (2.64)c
Note: Ages and scores are reported as mean and SD.
Abbreviations: BASIC, Brief Assessment of Impaired Cognition; BASIC-Q, Brief Assessment of Impaired Cognition Questionnaire; MCI, mild cognitive
impairment; MMSE, Mini-Mental State Examination.
aMCI vs control sample comparison: P < .001 (two-tailed).
bMCI vs control sample comparison: P < .01 (two-tailed).
cMCI vs dementia sample comparison: P < .001 (two-tailed).
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(t [123] = 3.27, P = .002, g = 0.79), Supermarket Fluency (t [123] = 4.51,
P < .001, g = 0.96), and Orientation (t [123] = 2.90, P = .006, g = 0.70;
Table 2). Significant differences were also present between the MCI
and dementia group on BASIC, BASIC-Q and their components except
for self-report where mean scores (3.7) were identical in the two
groups.
3.1 | Discriminative validity
Using the AUC as a general index of discriminative validity, both
BASIC (AUC = 0.95) and BASIC-Q (AUC = 0.94) were accurate in dif-
ferentiating patients with MCI from control participants. In compari-
son, the MMSE had an AUC of 0.67 (Figure 2).
F IGURE 1 Boxplot of score
distribution for BASIC. The median for
each data set is indicated by the black
center line and the upper and lower
horizontal lines of each bar represent the
75th and 25th percentile scores,
respectively. Maximum and minimum
scores are depicted by the ends of the
lines extending from the boxes. Outliers
are indicated by small circles. The
horizontal reference line represents the
optimal cutoff score (21/22) for
differentiating between the MCI and
control group. BASIC, Brief Assessment
of Impaired Cognition; MCI, mild
cognitive impairment
F IGURE 2 Receiver operating
characteristics of BASIC, BASIC-Q, and
MMSE as case-finding tools for MCI vs
control sample. Areas under the ROC
curve (AUC): BASIC = 0.95 (95% CI
0.91-1.00); BASIC-Q = 0.94 (95% CI
0.89-0.99); MMSE = 0.67 (95% CI
0.56-0.77). BASIC, Brief Assessment of
Impaired Cognition; BASIC-Q, Brief
Assessment of Impaired Cognition
Questionnaire; MCI, mild cognitive
impairment; MMSE, Mini-Mental State
Examination
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Pairwise comparisons of ROC curves revealed that both
BASIC (z = 5.36, P < .001) and BASIC-Q (z = 4.84, P < .001) had
significantly higher classification accuracy than the MMSE. Dis-
criminative validity statistics for BASIC and BASIC-Q for identifi-
cation of MCI vs controls at different cutoff scores are presented
in Table 3.
A cutoff score of 21/22 on BASIC provided optimal discrimination
between the MCI and control group with high sensitivity (0.86) and spec-
ificity (0.89). This is in accordance with the score distribution for BASIC,
as 81 of 83 control participants scored in the range of 22 to 25, whereas
the majority of MCI participants scored below 21 (Figure 1). A roughly
similar classification accuracy (sensitivity 0.88, specificity 0.88) was found
for BASIC-Q at an optimal cutoff score of 17/18 (Table 3 and Figure S1).
By comparison, the MMSE had poor sensitivity (0.61) but moderate
specificity (0.72) at an optimal cutoff score of 28/29, and negligible sen-
sitivity (0.15) but maximum specificity (1.00) at the commonly applied
cutoff score of 23/24 (Table 3 and Figure S2).
The diagnostic classification performance of the individual com-
ponents of BASIC and BASIC-Q depends on the comparison condi-
tion. In the MCI vs control comparison all components contributed
significantly to the discriminative validity (Table 4).
Informant report (OR 7.84, AUC 0.90) and self-report (OR 3.87,
AUC 0.83) appear to have the strongest classification performance in
this comparison. Similarly, in the control vs dementia comparison con-
dition, all components of BASIC and BASIC-Q contributed signifi-
cantly to differentiating the two groups (Table S1). But in this
comparison, the classification performance of informant report
(OR 34.87, AUC 0.99) was markedly superior to self-report (OR 2.64,
AUC 0.79). In the MCI vs dementia comparison condition, mean self-
report scores were identical (3.7; Table 2), and the classification per-
formance of self-report was at chance level (OR 1.02, AUC 0.49;
Table S2). Predictive validity estimates for a range of scores below
and above the optimal cutoff at selected base rates of MCI are pres-
ented in Table S3.
TABLE 3 Classification accuracy of
BASIC, BASIC-Q, and MMSE for MCI vs
control sample at different cutoff scores
Cutoff Sensitivity (95% CI) Specificity (95% CI) LR+ LR−
BASIC 19/20 0.64 (0.48-0.78) 1.00 (0.94-1.00) N/A 0.36
20/21 0.83 (0.68-0.92) 0.98 (0.91-1.00) 34.58 0.17
21/22a 0.86 (0.71-0.94) 0.89 (0.80-0.95) 7.90 0.16
22/23 0.93 (0.79-0.98) 0.78 (0.68-0.86) 4.28 0.09
23/24 0.98 (0.86-1.00) 0.53 (0.42-0.64) 2.08 0.04
24/25 1.00 (0.90-1.00) 0.22 (0.14-0.32) 1.28 0.00
BASIC-Q 15/16 0.55 (0.39-0.70) 1.00 (0.94-1.00) N/A 0.45
16/17 0.79 (0.63-0.89) 0.98 (0.91-1.00) 32.61 0.22
17/18a 0.88 (0.74-0.96) 0.88 (0.79-0.94) 7.31 0.14
18/19 0.93 (0.79-0.98) 0.67 (0.56-0.77) 2.85 0.11
19/20 0.98 (0.86–1.00) 0.41 (0.30-0.52) 1.65 0.06
MMSE 23/24b 0.15 (0.06-0.30) 1.00 (0.94–1.00) N/A 0.85
28/29a 0.61 (0.45-0.75) 0.72 (0.61-0.81) 2.20 0.54
Abbreviations: BASIC, Brief Assessment of Impaired Cognition; BASIC-Q, Brief Assessment of Impaired Cognition Questionnaire; CI, confidence interval;
LR+, positive likelihood ratio; LR−, negative likelihood ratio; MCI, mild cognitive impairment; MMSE, Mini-Mental State Examination.
aOptimal cutoff score for discrimination between MCI and control sample.
bCommonly applied cutoff score for MMSE.
TABLE 4 Classification performance
of BASIC, BASIC-Q, and their separate
components for differentiating MCI from
control participants
OR 95% CI P AUC
BASIC 3.39 2.17 to 5.31 <.001 0.95
BASIC-Q 3.92 2.37 to 6.50 <.001 0.94
MMSE 1.36 1.13 to 1.63 .001 0.67
Components of BASIC and BASIC-Q:
• Self-report 3.87 2.33 to 6.45 <.001 0.83
• Informant report 7.84 3.61 to 17.06 <.001 0.90
• Category cued memory test 2.36 1.45 to 3.83 .001 0.63
• Supermarket fluency 2.57 1.66 to 3.97 <.001 0.72
• Orientation 2.89 1.47 to 5.68 .002 0.61
Note: Odds ratios, 95% CI, and P from logistic regression.
Abbreviations: AUC, area under the ROC curve; BASIC, Brief Assessment of Impaired Cognition; BASIC-Q, Brief Assessment of Impaired Cognition Ques-
tionnaire; CI, confidence interval; MCI, mild cognitive impairment; MMSE, Mini-Mental State Examination; OR, odds ratio.
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4 | DISCUSSION
This study validated BASIC and BASIC-Q as case-finding instruments
for MCI in a memory clinic setting. A high discriminative validity for
both BASIC (sensitivity 0.86, specificity 0.89) and BASIC-Q (sensitivity
0.88, specificity 0.88) was found for identification of MCI vs
sociodemographically matched control participants. In comparison,
the MMSE optimally had a sensitivity of 0.61 and a specificity of 0.72
for identification of MCI. Statistical comparison of ROC curves indi-
cated that both BASIC and BASIC-Q had significantly higher classifica-
tion accuracy than MMSE.
The data regarding the score distribution for MMSE indicate a
ceiling effect in the MCI group (Figure S2), whereas no ceiling effect
appears to be present for BASIC (Figure 1) or BASIC-Q (Figure S1).
Both instruments are relatively unaffected by education, age, and
gender,29,30 they are easy to use, and can be administered in 5 minutes
or less compared to the approximately 10 minutes necessary for
administering the MMSE or MoCA. MoCA was introduced in 2005
and has eventually become the standard instrument for identification
of MCI.24,26 According to a meta-analysis of 9 studies, MoCA has high
sensitivity (0.89; 95% CI 0.84-0.92) for identification of MCI and mod-
erate specificity (0.75; 95% CI; 0.62-0.85).24 The diagnostic accuracy
of MoCA partly depends on the cutoff score.52 In the primary MoCA
validation study, a sensitivity of 0.90 and a specificity of 0.87 was
found using a cutoff score of 25/26,12 but results from subsequent
studies indicate that a cutoff score of 22/23 yields better diagnostic
accuracy.53,54 A possible alternative to MoCA is the Quick Mild Cog-
nitive Impairment Screen (Qmci)55 which is shorter and appears to
have better classification accuracy than MoCA.56 Although BASIC and
BASIC-Q appear to be as accurate as MoCA or Qmci, a direct compar-
ison is presently not possible as diagnostic accuracy statistics are
essentially sample-dependent. This should be addressed in future
studies.
Although this is not a longitudinal study, comparison of the mean
component scores across the three participant groups may provide
insight on the relative validity of the components at different stages
of cognitive decline (Table 2). All component scores decrease in the
MCI group compared to the control group and component scores fur-
ther decrease in the dementia group compared to the MCI group,
except for self-report where mean scores are identical in the two cog-
nitively impaired groups. The results indicate that self-report may be a
valid indicator of cognitive impairment in MCI, but the discriminative
validity of self-report decreases with the onset of dementia, possibly
due to lack of insight (Table 4; Tables S1 and S2). In comparison, infor-
mant report, orientation and the two brief cognitive tests yield valid
diagnostic information in both MCI and dementia. Relative to the
other components, the validity of informant report seems to increase
with the progression of cognitive impairment. Similar results regarding
the validity of self- and informant report have been reported in stud-
ies using the Cognitive Function Instrument (CFI) that combines simi-
larly phrased self- and informant report versions of the same
questionnaire.35 According to a longitudinal study, both CFI versions
were associated with cognitive decline during 4-year follow-up. But
self-report appeared more accurate when the respondent was cogni-
tively intact, whereas the accuracy of informant report improved con-
currently with cognitive impairment.35,57 In a Norwegian validation
study, both versions of the CFI discriminated between people with
dementia and those with either MCI, subjective cognitive impairment,
or a reference group.58 But again, the informant report version of CFI
had better discriminatory power than the self-report version in the
dementia stage.
Although the classification performance of BASIC and BASIC-Q for
MCI is similar, we recommend the longer BASIC in clinical settings, as it
provides more detailed information on cognitive functioning than
BASIC-Q. Also, BASIC contains a larger proportion of “objective” mea-
sures of cognitive functioning compared to BASIC-Q, possibly preserv-
ing the validity of BASIC in situations where the patient lacks insight.
In the present sample, the optimal cutoff scores for separation of
persons with MCI from control participants was 21/22 for BASIC and
17/18 for BASIC-Q. However, when evaluating the performance of an
individual person, optimal group separation is not the focus of interest.
Instead, the probability of MCI vs the probability of being cognitively
intact associated with a given performance is more relevant. We there-
fore present predictive validity estimates for different base rates of
MCI (Table S3). In Danish memory, clinics approximately 25% of the
patients referred for assessment are assigned an MCI diagnosis.10
In this setting, both PPV (0.72) and NPV (0.95) seem acceptable.
But in a low base rate setting, for example, a general practice setting,
PPV is attenuated (0.30) due to a higher proportion of false positive
cases. For instance, in a 5% base rate setting a downwards adjustment
of the BASIC cutoff score to 20/21 or even 19/20 may be considered
in order to ensure an acceptable PPV. A high NPV is also desirable in
a general practice setting, but this requirement appears easily met for
BASIC and BASIC-Q as NPV for both instruments is in the 0.98 to
1.00 range depending on cutoff score.
The patients in this study were referred from general practice and
undiagnosed at the time of assessment. As BASIC and BASIC-Q had no
influence on subsequent clinical diagnosis, the risk of circular evidence
was minimal. Among the limitations of the study is the relatively small
MCI sample and the fact that we did not have access to neuropsycho-
logical assessment results or AD biomarker data as patients were exam-
ined at five different sites. Consequently, we were not able to perform
independent verification of MCI-diagnoses or conduct a subtyping of
MCI-cases based on neuropsychological profiles (eg, amnestic vs non-
amnestic MCI) or biomarkers (eg, prodromal vs non-prodromal AD). A
further limitation is the fact that data were collected exclusively in a
memory clinic setting. Our clinical sample may be representative for per-
sons referred from general practice at their first memory clinic admission,
but not for a general practice or primary care setting. Future studies are
needed to cross-validate BASIC and BASIC-Q in these settings.
5 | CONCLUSION
The results of this study indicate that both BASIC and BASIC-Q meet
criteria for accurate, time-saving, and easy-to-use tools for
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identification of MCI in a memory clinic setting. Both instruments
appear to be sensitive and specific for identification of MCI among
persons referred from general practice for expert diagnostic evalua-
tion. It must be emphasized, though, that neither instrument can sub-
stitute expert clinical evaluation. A diagnosis of MCI cannot be based
solely on a brief case-finding instrument, but BASIC and BASIC-Q
appear to be effective tools for identifying patients for whom further
diagnostic assessment should be considered.
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